Public Comment

Nebraska’s voter-created Medical Cannabis Commission continued developing licensing fees and regulations in 2026, and the state approved its first cultivation activity under the emerging system. The central dispute is whether regulators are moving cautiously enough to protect patients and public safety or imposing rules that make the voter-approved program too limited, costly, or slow to function. A vertically integrated cannabis license allows one business to perform multiple stages such as cultivation, processing, distribution, or dispensing. Patients voted for access, not just a commission and paperwork. Regulation should control product safety and diversion without making legal medicine practically unavailable.

What would count as faithful implementation of Nebraska’s medical-cannabis vote?

Overall results

1
63% support
7

Competitive licensing with testing and seed-to-sale tracking can improve affordability while preserving oversight and traceability.

7

Patients in rural areas need enough dispensaries and product forms to avoid hours of travel or dependence on an unregulated market.

2
47% support · excluded by 16%
7

Reviews should measure patient enrollment, travel distance, product testing, prices, supply shortages, and enforcement outcomes.

7

A phased launch allows regulators to identify safety and supply problems before expanding while still committing to a functioning patient program.

3
46% support · excluded by 12%
7

If the approved system cannot operate without a costly new bureaucracy and conflicts with federal law, voters should reconsider the policy directly.

4
44% support · excluded by 6%
7

Nebraska should begin with tight limits because a broad commercial market would be difficult to reverse if diversion and impaired driving increase.

About the author